Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1971 1
1973 2
1974 3
1975 6
1976 2
1977 2
1978 4
1979 1
1980 3
1981 7
1982 3
1983 8
1984 8
1985 4
1986 8
1987 4
1988 6
1989 4
1990 8
1991 5
1992 11
1993 6
1994 4
1995 5
1996 2
1997 4
1998 7
1999 4
2000 5
2001 5
2002 7
2003 3
2004 4
2005 7
2006 9
2007 4
2008 4
2009 7
2010 7
2011 5
2012 15
2013 18
2014 18
2015 20
2016 14
2017 28
2018 23
2019 25
2020 22
2021 24
2022 28
2023 25
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

436 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Harris PNA, et al. JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. JAMA. 2018. PMID: 30208454 Free PMC article. Clinical Trial.
IMPORTANCE: Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella pneumoniae. ...Nonfatal serious adverse events occurred in 5 of 188 patients (2.7%) in the piperacillin-ta …
IMPORTANCE: Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherich …
Drug Resistance Patterns of Escherichia coli in Ethiopia: A Meta-Analysis.
Tuem KB, Gebre AK, Atey TM, Bitew H, Yimer EM, Berhe DF. Tuem KB, et al. Biomed Res Int. 2018 May 6;2018:4536905. doi: 10.1155/2018/4536905. eCollection 2018. Biomed Res Int. 2018. PMID: 29854757 Free PMC article. Review.
Therefore, this study intended to assess the prevalence of E. coli resistance and antimicrobial-specific resistance pattern among E. coli clinical isolates in Ethiopia. ...The highest resistance of E. coli reported was to ampicillin (83.8 …
Therefore, this study intended to assess the prevalence of E. coli resistance and antimicrobial-specific resistance pat …
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.
Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J; REIPI-GEIRAS-FOREST group. Sojo-Dorado J, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277. JAMA Netw Open. 2022. PMID: 35024838 Free PMC article. Clinical Trial.
IMPORTANCE: The consumption of broad-spectrum drugs has increased as a consequence of the spread of multidrug-resistant (MDR) Escherichia coli. Finding alternatives for these infections is critical, for which some neglected drugs may be an option. ...In an ex …
IMPORTANCE: The consumption of broad-spectrum drugs has increased as a consequence of the spread of multidrug-resistant (MDR) Esch …
Uropathogenic Escherichia coli in Mexico, an Overview of Virulence and Resistance Determinants: Systematic Review and Meta-analysis.
Ballesteros-Monrreal MG, Mendez-Pfeiffer P, Barrios-Villa E, Arenas-Hernández MMP, Enciso-Martínez Y, Sepúlveda-Moreno CO, Bolado-Martínez E, Valencia D. Ballesteros-Monrreal MG, et al. Arch Med Res. 2023 Apr;54(3):247-260. doi: 10.1016/j.arcmed.2023.01.001. Epub 2023 Jan 30. Arch Med Res. 2023. PMID: 36725379 Review.
BACKGROUND: Urinary tract infections (UTI) are one of the most common pathologies in Mexico and the majority are caused by uropathogenic Escherichia coli (UPEC). UPEC possesses virulence and resistance determinants that promote UTI development and affect diag …
BACKGROUND: Urinary tract infections (UTI) are one of the most common pathologies in Mexico and the majority are caused by uropathogenic …
Phylogenetic Group Distribution of Uropathogenic Escherichia coli and Related Antimicrobial Resistance Pattern: A Meta-Analysis and Systematic Review.
Halaji M, Fayyazi A, Rajabnia M, Zare D, Pournajaf A, Ranjbar R. Halaji M, et al. Front Cell Infect Microbiol. 2022 Feb 25;12:790184. doi: 10.3389/fcimb.2022.790184. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35281449 Free PMC article. Review.
The phylogenetic classification of Escherichia coli isolates is of great importance not only for understanding the populations of E. coli but also for clarifying the relationship between strains and diseases. The present study aimed to evaluate the prevalence …
The phylogenetic classification of Escherichia coli isolates is of great importance not only for understanding the populations …
Antibiotic resistance of fecal carriage of Escherichia coli from pig farms in China: a meta-analysis.
Li M, Li Z, Zhong Q, Liu J, Han G, Li Y, Li C. Li M, et al. Environ Sci Pollut Res Int. 2022 Apr;29(16):22989-23000. doi: 10.1007/s11356-021-17339-z. Epub 2021 Nov 19. Environ Sci Pollut Res Int. 2022. PMID: 34797542
Fecal carriage of bacteria is a major source of antibiotic resistance genes (ARGs) and a public health risk, but the antibiotic resistance of Escherichia coli (E. coli) in Chinese pig farms remains a major gap in the available literature. Our go …
Fecal carriage of bacteria is a major source of antibiotic resistance genes (ARGs) and a public health risk, but the antibiotic re …
Prevalence of antibiotic susceptibility and resistance of Escherichia coli in acute uncomplicated cystitis in Korea: Systematic review and meta-analysis.
Kim JH, Sun HY, Kim TH, Shim SR, Doo SW, Yang WJ, Lee EJ, Song YS. Kim JH, et al. Medicine (Baltimore). 2016 Sep;95(36):e4663. doi: 10.1097/MD.0000000000004663. Medicine (Baltimore). 2016. PMID: 27603359 Free PMC article. Review.
BACKGROUND: The aim of this study is to determine the prevalence of antibiotic susceptibility and resistance of Escherichia coli Escherichia coli (E coli) in female uncomplicated cystitis in Korea using meta-analysis. ...Observational or …
BACKGROUND: The aim of this study is to determine the prevalence of antibiotic susceptibility and resistance of Escherichia …
RETRACTED: Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta-analysis.
Wang WY, Zhou H, Wang Z, Zhang YH. Wang WY, et al. Cancer Treat Res Commun. 2022;32:100536. doi: 10.1016/j.ctarc.2022.100536. Epub 2022 Feb 22. Cancer Treat Res Commun. 2022. PMID: 35567912 Free article. Retracted. Review.
The reasons include that the results are not comparable to the diagnostic performance of three bacteria species in 5-fluorouracil resistance in CRC from the clinical studies which are conducted to detect each type of bacteria separately. ...
The reasons include that the results are not comparable to the diagnostic performance of three bacteria species in 5-fluorouracil resista …
Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies.
Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Fasugba O, et al. BMC Infect Dis. 2015 Nov 25;15:545. doi: 10.1186/s12879-015-1282-4. BMC Infect Dis. 2015. PMID: 26607324 Free PMC article. Review.
BACKGROUND: During the last decade the resistance rate of urinary Escherichia coli (E. coli) to fluoroquinolones such as ciprofloxacin has increased. ...Similarly, a significant rise in resistance over time was seen in studies reporting on commu …
BACKGROUND: During the last decade the resistance rate of urinary Escherichia coli (E. coli) to fluoroquinolones …
Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
Ten Doesschate T, Kuiper S, van Nieuwkoop C, Hassing RJ, Ketels T, van Mens SP, van den Bijllaardt W, van der Bij AK, Geerlings SE, Koster A, Koldewijn EL, Branger J, Hoepelman AIM, van Werkhoven CH, Bonten MJM; FORECAST Study Team. Ten Doesschate T, et al. Clin Infect Dis. 2022 Aug 25;75(2):221-229. doi: 10.1093/cid/ciab934. Clin Infect Dis. 2022. PMID: 34791074 Free PMC article. Clinical Trial.
BACKGROUND: We aimed to determine the noninferiority of fosfomycin compared to ciprofloxacin as an oral step-down treatment for Escherichia coli febrile urinary tract infections (fUTIs) in women. ...CONCLUSIONS: Fosfomycin is noninferior to ciprofloxacin as oral ste …
BACKGROUND: We aimed to determine the noninferiority of fosfomycin compared to ciprofloxacin as an oral step-down treatment for Escherich …
436 results

Searches related to "escherichia coli resistance"